title: Potential risks of using LABAs with ICS therapy.
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
authors.forename: Meme
authors.initials: M
authors.lastname: Wijesinghe
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic
chemical_list: D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists